ConductScience.org, home

Trial · NCT07890129

Stopping Blood Pressure Medications Without Tapering in Long-Term Care

NCT07890129, Not applicable, Completed, University of Alberta

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Stopping Blood Pressure Medications Without Tapering in Long-Term Care. Trials, record NCT07890129. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07890129

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Stopping Blood Pressure Medications Without Tapering in Long-Term Care
NCT number
NCT07890129
Status
Completed
Phases
Not applicable
Enrollment
11 participants, actual
Lead sponsor
University of Alberta
Conditions
Hypertension (HTN)
Interventions
Deprescribing antihypertensives without a taper
First posted
2026-10-22
Last updated
2026-10-22

Source ClinicalTrials.gov

Registered outcomes5

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimarySuccessful Antihypertensive DeprescribingIn the four weeks after medication discontinuationProportion of participants who discontinued one antihypertensive medication without tapering and remained off that medication for four weeks.
SecondaryChange in Systolic and Diastolic Blood PressureBaseline and four weeks after medication discontinuationChange in systolic and diastolic blood pressure from baseline to the end of the four-week follow-up period.
SecondaryChange in As-Needed Medication UseThree months before and four weeks after medication discontinuationChange in the monthly number of as-needed medication administrations before and after stopping antihypertensive medication
SecondaryChange in Number of FallsSix months before and four weeks after medication discontinuationChange in the number of falls before and after stopping antihypertensive medication
SecondaryChange in Meal IntakeFour weeks before and four weeks after medication discontinuationChange in the percentage of meals consumed before and after stopping antihypertensive medication, assessed using categories of 0-25%, 26-50%, 51-75%, and over 75%

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07890129

GET https://conductscience.org/api/trials/v1/NCT07890129/registered